Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae

Marco R. Oggioni, Francesco Iannelli, Susanna Ricci, Damiana Chiavolini, Riccardo Parigi, Claudia Trappetti, Jean Pierre Claverys, Gianni Pozzi

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Streptococcus pneumoniae, a major cause of human disease, produces a 17-mer autoinducer peptide pheromone (competence-stimulating peptide [CSP]) for the control of competence for genetic transformation. Due to previous work linking CSP to stress phenotypes, we set up an in vivo sepsis model to assay its effect on virulence. Our data demonstrate a significant increase in the rates of survival of mice, reductions of blood S. pneumoniae counts, and prolonged times to death for mice treated with CSP. In vitro the dose of CSP used in the animal model produced a transitory inhibition of growth. When a mutant with a mutation in the CSP sensor histidine kinase was assayed, no bacteriostatic phenotype was detected in vitro and no change in disease outcome was observed in vivo. The data demonstrate that CSP, which induces in vitro a temporary growth arrest through stimulation of its cognate histidine kinase receptor, is able to block systemic disease in mice. This therapeutic effect is novel, in that the drug-like effect is obtained by stimulation, rather than inhibition, of a bacterial drug target.

Original languageEnglish (US)
Pages (from-to)4725-4732
Number of pages8
JournalAntimicrobial Agents and Chemotherapy
Volume48
Issue number12
DOIs
StatePublished - Dec 1 2004

Fingerprint

Streptococcus pneumoniae
Mental Competency
Sepsis
Peptides
Genetic Transformation
Phenotype
Pheromones
Therapeutic Uses
Growth
Pharmaceutical Preparations
Virulence
Survival Rate
Animal Models
Mutation
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae. / Oggioni, Marco R.; Iannelli, Francesco; Ricci, Susanna; Chiavolini, Damiana; Parigi, Riccardo; Trappetti, Claudia; Claverys, Jean Pierre; Pozzi, Gianni.

In: Antimicrobial Agents and Chemotherapy, Vol. 48, No. 12, 01.12.2004, p. 4725-4732.

Research output: Contribution to journalArticle

Oggioni, Marco R. ; Iannelli, Francesco ; Ricci, Susanna ; Chiavolini, Damiana ; Parigi, Riccardo ; Trappetti, Claudia ; Claverys, Jean Pierre ; Pozzi, Gianni. / Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae. In: Antimicrobial Agents and Chemotherapy. 2004 ; Vol. 48, No. 12. pp. 4725-4732.
@article{4e4d1e21d8364cf99186471035268568,
title = "Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae",
abstract = "Streptococcus pneumoniae, a major cause of human disease, produces a 17-mer autoinducer peptide pheromone (competence-stimulating peptide [CSP]) for the control of competence for genetic transformation. Due to previous work linking CSP to stress phenotypes, we set up an in vivo sepsis model to assay its effect on virulence. Our data demonstrate a significant increase in the rates of survival of mice, reductions of blood S. pneumoniae counts, and prolonged times to death for mice treated with CSP. In vitro the dose of CSP used in the animal model produced a transitory inhibition of growth. When a mutant with a mutation in the CSP sensor histidine kinase was assayed, no bacteriostatic phenotype was detected in vitro and no change in disease outcome was observed in vivo. The data demonstrate that CSP, which induces in vitro a temporary growth arrest through stimulation of its cognate histidine kinase receptor, is able to block systemic disease in mice. This therapeutic effect is novel, in that the drug-like effect is obtained by stimulation, rather than inhibition, of a bacterial drug target.",
author = "Oggioni, {Marco R.} and Francesco Iannelli and Susanna Ricci and Damiana Chiavolini and Riccardo Parigi and Claudia Trappetti and Claverys, {Jean Pierre} and Gianni Pozzi",
year = "2004",
month = "12",
day = "1",
doi = "10.1128/AAC.48.12.4725-4732.2004",
language = "English (US)",
volume = "48",
pages = "4725--4732",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae

AU - Oggioni, Marco R.

AU - Iannelli, Francesco

AU - Ricci, Susanna

AU - Chiavolini, Damiana

AU - Parigi, Riccardo

AU - Trappetti, Claudia

AU - Claverys, Jean Pierre

AU - Pozzi, Gianni

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Streptococcus pneumoniae, a major cause of human disease, produces a 17-mer autoinducer peptide pheromone (competence-stimulating peptide [CSP]) for the control of competence for genetic transformation. Due to previous work linking CSP to stress phenotypes, we set up an in vivo sepsis model to assay its effect on virulence. Our data demonstrate a significant increase in the rates of survival of mice, reductions of blood S. pneumoniae counts, and prolonged times to death for mice treated with CSP. In vitro the dose of CSP used in the animal model produced a transitory inhibition of growth. When a mutant with a mutation in the CSP sensor histidine kinase was assayed, no bacteriostatic phenotype was detected in vitro and no change in disease outcome was observed in vivo. The data demonstrate that CSP, which induces in vitro a temporary growth arrest through stimulation of its cognate histidine kinase receptor, is able to block systemic disease in mice. This therapeutic effect is novel, in that the drug-like effect is obtained by stimulation, rather than inhibition, of a bacterial drug target.

AB - Streptococcus pneumoniae, a major cause of human disease, produces a 17-mer autoinducer peptide pheromone (competence-stimulating peptide [CSP]) for the control of competence for genetic transformation. Due to previous work linking CSP to stress phenotypes, we set up an in vivo sepsis model to assay its effect on virulence. Our data demonstrate a significant increase in the rates of survival of mice, reductions of blood S. pneumoniae counts, and prolonged times to death for mice treated with CSP. In vitro the dose of CSP used in the animal model produced a transitory inhibition of growth. When a mutant with a mutation in the CSP sensor histidine kinase was assayed, no bacteriostatic phenotype was detected in vitro and no change in disease outcome was observed in vivo. The data demonstrate that CSP, which induces in vitro a temporary growth arrest through stimulation of its cognate histidine kinase receptor, is able to block systemic disease in mice. This therapeutic effect is novel, in that the drug-like effect is obtained by stimulation, rather than inhibition, of a bacterial drug target.

UR - http://www.scopus.com/inward/record.url?scp=9644259079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644259079&partnerID=8YFLogxK

U2 - 10.1128/AAC.48.12.4725-4732.2004

DO - 10.1128/AAC.48.12.4725-4732.2004

M3 - Article

VL - 48

SP - 4725

EP - 4732

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -